3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4 Warshada Dhexe ee Argatroban 98.0%
Dhexdhexaadiyeyaasha la xidhiidha saadka saaraha Argatroban:
Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
Magaca Kiimikada | 3-Methyl-8-Quinolinesulphonyl Chloride |
La mid ah | 3-Methylquinoline-8-Sulfonyl Chloride |
Lambarka CAS | 74863-82-4 |
Lambarka CAT | RF-PI269 |
Heerka Saamiyada | Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan |
Qaanuunka molecular | C10H8ClNO2S |
Miisaanka Molecular | 241.69 |
Cufnaanta | 1.4±0.1 g/cm3 |
Tusmada Dib-u-celinta | 1.63 |
Solubility | Ku milmay chloroform |
Xaalada Maraakiibta | Lagu soo raray Heer kulka jawiga |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Budada Crystalline White |
Daahirnimada / Habka Falanqaynta | >98.0% (HPLC) |
Meesha dhalaalaysa | 162.0 ~ 163.0 ℃ |
Khasaare xagga qalajinta | <0.50% |
3-Methylquinoline-8-Sulfonic Acid | <1.00% |
Wadarta wasakhda | <2.00% |
Infrared Spectrum | Waafaqsan Qaab-dhismeedka |
NMR | Waafaqsan Qaab-dhismeedka |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyaha Argatroban (CAS 74863-84-6) |
Xidhmada: Dhalo, bacda bireed aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka & qoyaanka
Shanghai Ruifu Kiimikada Co., Ltd. waa soo saaraha iyo soo saaraha 3-Methyl-8-Quinolinesulphonyl Chloride (CAS: 74863-82-4) oo leh tayo sare leh, oo si ballaaran loogu isticmaalo isku-dhafka dabiiciga ah, isku-darka dhexdhexaadiyeyaasha dawooyinka iyo Walxaha Farmashitada Active (API) isku xidhkaWaxaawaa dhexdhexaad caadi ahaan ku jira isku dhafka Argatroban (CAS: 74863-84-6) ama Argatroban Monohydrate (CAS 141396-28-3).
Argatroban (CAS: 74863-84-6) waa daawada xinjirowga lidka ku ah oo ah molecule yar oo si toos ah xannibaadaha thrombin.Sannadkii 2000, argatroban waxa shati ka siisay Maamulka Cuntada iyo Dawooyinka (FDA) ka hortagga ama daawaynta xinjirowga bukaanka qaba heparin-induced thrombocytopenia (HIT).Sannadkii 2002, waxaa la oggolaaday in la isticmaalo inta lagu guda jiro waxqabadyada xididdada xididdada dhiigga ee bukaannada qaba HIT ama khatarta ugu jira inay yeeshaan.Sannadkii 2012, waxa ay MHRA ee UK u ansixisay ka-hortagga xinjirowga lidka ku ah bukaannada qaba heparin-induced thrombocytopenia Nooca II (HIT) kuwaas oo u baahan daawaynta antithrombotic parenteral.